"Overall, these new antifungal drugs raise hope that replenishing the arsenal of therapeutic options for invasive fungal infections might be possible."

https://www.thelancet.com/journals/laninf/home Protective immunity of SARS-CoV-2 infection and vaccines against medically attended symptomatic omicron BA.4, BA.5, and XBB reinfections in Singapore: a national cohort study https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(23)00060-9/fulltext An exciting time for antifungal therapy The Lancet Infectious Diseases https://www.thelancet.com/journals/laninf/issue/current